Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II.
S Lindman, G Lindeberg, F Nyberg, A Karlén, A Hallberg
Index: Bioorg. Med. Chem. 8(9) , 2375-83, (2000)
Full Text: HTML
Abstract
Rigidification of peptides by cyclization and iterative incorporation of well-defined secondary structure mimetics constitutes one approach to the design of non-peptidergic structures with better defined conformations. We herein present the synthesis of a potential gamma-turn mimetic scaffold, and its incorporation in the 3-5 position of angiotensin II. Two analogues of angiotensin II (Ang II) incorporating this 1,3,5-trisubstituted benzene gamma-turn scaffold were synthesized. Evaluation of the compounds in a radioligand binding assay showed that they lacked affinity to the AT1 receptor. To rationalize these results a geometrical and electrostatical comparison with Ang II analogues encompassing a bicyclic scaffold that delivered inactive pseudo peptides and an azepine scaffold producing highly active ligands was made. This analysis did not provide a clear rationale for the inactivity of the benzene gamma-turn scaffolds.
Related Compounds
Related Articles:
Reaction of iodonium ylides of 1,3-dicarbonyl compounds with HF reagents.
2012-01-01
[Molecules 17(6) , 6625-32, (2012)]
A scalable synthesis of the thromboxane receptor antagonist 3-{3-[2-(4-chlorobenzenesulfonamido) ethyl]-5-(4-fluorobenzyl) phenyl} propionic acid via a regioselective Heck cross-coupling strategy. Waite DC and Mason CP.
[Org. Process Res. Dev. 2(2) , 116-20, (1998)]
Synthesis of acetylene-functionalized [2]rotaxane monomers directed toward side chain-type polyrotaxanes. Nakazono K, et al.
[Polymer J. 42(3) , 208-15, (2010)]